Objective: The primary aim of this article is to test the hypothesis that nonparametric pharmacometric modeling will accurately identify CYP2B6 genotype subgroups based on data from a study that reported results based on parametric pharmacokinetics (PK). Methods: Propofol concentration-time data were originally reported in the Kansaku et al., 2011 publication. Nonparametric Nonlinear Mixed Effects Modeling (NLME) was conducted using the PMETRICS R package while population pharmacokinetic model parameters were estimated using a FORTRAN compiler. Finally, model-based dosing simulations were conducted in the MATLAB Simbiology. Results: A total of 51 patients were included in the final PK analysis. A two-compartment gamma multiplicative error m...
KEY WORDS propofol; pharmacokinetics; age factors AIM: To analyze population pharmacokinetics of pro...
Background: To study propofol pharmacodynamics in a clinical setting a pharmacokinetic model must be...
Propofol is an intravenous anaesthetic agent used for the induction and maintenance of general anaes...
BACKGROUND: Pharmacokinetic (PK) models are used to predict drug concentrations for infusion regimen...
BACKGROUND: Pharmacokinetic (PK) models are used to predict drug concentrations for infusion regimen...
Aim: The aim of this study was to develop a population PK model for propofol in adults that could be...
Background: Pharmacokinetic (PK) and pharmacodynamic (PD) models are used in target-controlled-infus...
Background: Target-controlled infusion (TCI) systems are used to facilitate anesthetic drug administ...
Background: Target-controlled infusion (TCI) systems incorporating pharmacokinetic (PK) or PK-pharma...
Background: To study propofol pharmacodynamics in a clinical setting a pharmacokinetic model must be...
The purpose of this study was to determine the polymorphisms of UGT1A9 and CYP2B6 the effects of the...
KEY WORDS propofol; pharmacokinetics; age factors AIM: To analyze population pharmacokinetics of pro...
Background: To study propofol pharmacodynamics in a clinical setting a pharmacokinetic model must be...
Propofol is an intravenous anaesthetic agent used for the induction and maintenance of general anaes...
BACKGROUND: Pharmacokinetic (PK) models are used to predict drug concentrations for infusion regimen...
BACKGROUND: Pharmacokinetic (PK) models are used to predict drug concentrations for infusion regimen...
Aim: The aim of this study was to develop a population PK model for propofol in adults that could be...
Background: Pharmacokinetic (PK) and pharmacodynamic (PD) models are used in target-controlled-infus...
Background: Target-controlled infusion (TCI) systems are used to facilitate anesthetic drug administ...
Background: Target-controlled infusion (TCI) systems incorporating pharmacokinetic (PK) or PK-pharma...
Background: To study propofol pharmacodynamics in a clinical setting a pharmacokinetic model must be...
The purpose of this study was to determine the polymorphisms of UGT1A9 and CYP2B6 the effects of the...
KEY WORDS propofol; pharmacokinetics; age factors AIM: To analyze population pharmacokinetics of pro...
Background: To study propofol pharmacodynamics in a clinical setting a pharmacokinetic model must be...
Propofol is an intravenous anaesthetic agent used for the induction and maintenance of general anaes...